Selected article for: "tail vein and vein injection"

Author: Vere Hodge, R Anthony
Title: Meeting report: 30th International Conference on Antiviral Research, in Atlanta, GA, USA
  • Document date: 2018_6_28
  • ID: tudwns0r_26
    Snippet: In collaboration with Mike Sofia (this ICAR's Elion awardee), FMCA-P was tested in an immunodeficient mouse model of HBV. Entecavir was the positive control. The drugs were administered by hydrodynamic injection (this technique enables larger injection volumes to be administered via the tail vein; prior to injection, the mice are placed in a warm box to enlarge the tail vein). David kindly shared some unpublished, preliminary results; FMCA-P had .....
    Document: In collaboration with Mike Sofia (this ICAR's Elion awardee), FMCA-P was tested in an immunodeficient mouse model of HBV. Entecavir was the positive control. The drugs were administered by hydrodynamic injection (this technique enables larger injection volumes to be administered via the tail vein; prior to injection, the mice are placed in a warm box to enlarge the tail vein). David kindly shared some unpublished, preliminary results; FMCA-P had sufficient activity to encourage further work.

    Search related documents:
    Co phrase search for related documents
    • HBV mouse model and hydrodynamic injection: 1, 2
    • HBV mouse model and mouse model: 1, 2, 3, 4, 5, 6, 7, 8
    • hydrodynamic injection and mouse model: 1, 2
    • hydrodynamic injection and tail vein: 1, 2